The risk factors and symptoms for subclinical lower extremity peripheral arterial disease (PAD) have not been well characterized in Hispanics, and even less in Mexican Americans. This is despite common cardiovascular risk factors, such as diabetes and obesity, being prevalent in these populations. The aim of this study was to assess the multivariate PAD associations, describe the symptoms of subclinical PAD, and characterize the walking impairment in a population sample of Mexican American adults in Cameron County, Texas. The Cameron County Hispanic Cohort (CCHC) is a prospective, randomly- ascertained, population-based cohort that assesses demographic and clinical characteristics from MA households in Cameron County, Texas. In addition to ...
Click on the DOI link to access the article (may not be free).African Americans are at increased ris...
Objective: The aim of this study is to determine gender differences in the risk factor profile and l...
Background Underuse of cardiovascular medications for secondary prevention among individuals with pe...
The risk factors and symptoms for subclinical lower extremity peripheral arterial disease (PAD) have...
ObjectiveBecause Hispanic ethnicity in the United States is heterogeneous, the purpose of this study...
Peripheral arterial disease (PAD) is a highly prevalent public health problem associated with major ...
BackgroundExperimental evidence suggests that sedentary time (ST) may contribute to cardiovascular d...
PurposeTo identify comorbidities associated with increased rates of functional decline in persons wi...
Click on the DOI link to access the article (may not be free).African Americans are two times more l...
Background and aimsPeripheral artery disease (PAD) and lower levels of physical activity are both as...
ObjectivesThe purpose of this study was to determine the association of family history of peripheral...
Abstract: Few studies have investigated whether ethnic groups differ in the prevalence of peripheral...
Background-—The prevalence and significance of low normal and abnormal ankle brachial index (ABI) va...
Introduction: Peripheral Artery Disease (PAD) affects 12 million people in the US. 11.7% in Pakistan...
IntroductionLower-extremity peripheral artery disease (PAD) is associated with traditional cardiovas...
Click on the DOI link to access the article (may not be free).African Americans are at increased ris...
Objective: The aim of this study is to determine gender differences in the risk factor profile and l...
Background Underuse of cardiovascular medications for secondary prevention among individuals with pe...
The risk factors and symptoms for subclinical lower extremity peripheral arterial disease (PAD) have...
ObjectiveBecause Hispanic ethnicity in the United States is heterogeneous, the purpose of this study...
Peripheral arterial disease (PAD) is a highly prevalent public health problem associated with major ...
BackgroundExperimental evidence suggests that sedentary time (ST) may contribute to cardiovascular d...
PurposeTo identify comorbidities associated with increased rates of functional decline in persons wi...
Click on the DOI link to access the article (may not be free).African Americans are two times more l...
Background and aimsPeripheral artery disease (PAD) and lower levels of physical activity are both as...
ObjectivesThe purpose of this study was to determine the association of family history of peripheral...
Abstract: Few studies have investigated whether ethnic groups differ in the prevalence of peripheral...
Background-—The prevalence and significance of low normal and abnormal ankle brachial index (ABI) va...
Introduction: Peripheral Artery Disease (PAD) affects 12 million people in the US. 11.7% in Pakistan...
IntroductionLower-extremity peripheral artery disease (PAD) is associated with traditional cardiovas...
Click on the DOI link to access the article (may not be free).African Americans are at increased ris...
Objective: The aim of this study is to determine gender differences in the risk factor profile and l...
Background Underuse of cardiovascular medications for secondary prevention among individuals with pe...